Quantedge Capital Pte LTD Alector, Inc. Transaction History

Quantedge Capital Pte LTD

  • $328 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$7.65 - $14.24 $123,930 - $230,688
-16,200 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$13.02 - $20.78 $61,194 - $97,666
4,700 Added 40.87%
16,200 $231,000
Q4 2021

Feb 11, 2022
BUY
$19.35 - $25.54 $222,525 - $293,710
11,500 New
11,500 $237,000

Others Institutions Holding ALEC

# of Institutions
168
Shares Held
57.8M
Call Options Held
146K
Put Options Held
90.8K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $153M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Quantedge Capital Pte LTD Portfolio

Follow Quantedge Capital Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantedge Capital Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quantedge Capital Pte LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email